WFA Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-627
Closed -$32.2K 239
2023
Q4
$32.2K Sell
627
-350
-36% -$18.4K 0.02% 118
2023
Q3
$56.7K Buy
977
+27
+3% +$1.65K 0.03% 88
2023
Q2
$60.8K Hold
950
0.04% 86
2023
Q1
$65.8K Buy
+950
New +$67K 0.04% 86

Other funds holding BMY

WFA Asset Management's BMY Position: Q1 2024 in Review

WFA Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 627 shares — an estimated $32.2K sold.

WFA Asset Management first reported a position in BMY in Q1 2023 and held it in 4 quarters. The position peaked at $65.8K in Q1 2023. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • WFA Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • WFA Asset Management sold 627 Bristol-Myers Squibb shares in Q1 2024, an estimated $32.2K.
  • WFA Asset Management first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 4 quarters.
  • WFA Asset Management's Bristol-Myers Squibb position peaked at $65.8K in Q1 2023.
  • 2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on WFA Asset Management's 13F filing for Q1 2024, filed 19 Apr 2024.